NanoGroup S.A. Logo

NanoGroup S.A.

Develops nanotech medical solutions for oncology, transplantology, diagnostics, and therapy.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

NanoGroup S.A. is a biotechnology company specializing in the development of innovative medical technologies based on a unique, patented nanotechnology platform. The company's research and development efforts are focused on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects in its portfolio include the nanoformulation of anticancer drugs, a human blood substitute, a fluid for the preservation of organs for transplantation, and nanoparticles for use in advanced diagnostics and therapy. The company operates as a group, advancing a portfolio of projects with the potential for global market expansion.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NanoGroup S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-10 09:20
Proxy Solicitation & Information Statement
Formularz do wykonywania prawa głosu przez pełnomocnika
Polish 58.7 KB
2025-09-10 09:20
Proxy Solicitation & Information Statement
Pełnomocnictwo os. prawna
Polish 51.4 KB
2025-09-10 09:20
Proxy Solicitation & Information Statement
Pełnomocnictwo os. fizyczna
Polish 49.1 KB
2025-09-10 09:20
Pre-Annual General Meeting Information
Projekty uchwał
Polish 150.9 KB
2025-09-10 09:20
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu NWZ
Polish 149.7 KB
2025-09-10 09:20
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Walnego Zgromadzenia NanoGroup S.A. - Content (PL)
Polish 21.0 KB
2025-08-28 18:14
Share Issue/Capital Change
Dookreślenie przez Zarząd wysokości kapitału zakładowego - Content (PL)
Polish 4.6 KB
2025-08-26 08:18
Share Issue/Capital Change
Zawarcie umów inwestorskich o łącznej wartości 17,0 mln PLN - Content (PL)
Polish 5.2 KB
2025-08-12 22:27
Director's Dealing
Powiadomienie
Polish 4.3 KB
2025-08-12 22:27
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 472 bytes
2025-08-12 22:20
Director's Dealing
Powiadomienie
Polish 4.3 KB
2025-08-12 22:20
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 466 bytes
2025-08-12 22:12
Director's Dealing
Powiadomienie
Polish 4.3 KB
2025-08-12 22:12
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 461 bytes
2025-08-12 22:04
Director's Dealing
Powiadomienie
Polish 4.3 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN

Talk to a Data Expert

Have a question? We'll get back to you promptly.